156 related articles for article (PubMed ID: 30199766)
1. Lack of chemokine (C-C motif) ligand 3 leads to decreased survival and reduced immune response after bacterial meningitis.
Aust V; Kress E; Abraham S; Schröder N; Kipp M; Stope MB; Pufe T; Tauber SC; Brandenburg LO
Cytokine; 2018 Nov; 111():246-254. PubMed ID: 30199766
[TBL] [Abstract][Full Text] [Related]
2. Lack of Toll-like receptor 2 results in higher mortality of bacterial meningitis by impaired host resistance.
Böhland M; Kress E; Stope MB; Pufe T; Tauber SC; Brandenburg LO
J Neuroimmunol; 2016 Oct; 299():90-97. PubMed ID: 27725130
[TBL] [Abstract][Full Text] [Related]
3. Role of the cathelicidin-related antimicrobial peptide in inflammation and mortality in a mouse model of bacterial meningitis.
Merres J; Höss J; Albrecht LJ; Kress E; Soehnlein O; Jansen S; Pufe T; Tauber SC; Brandenburg LO
J Innate Immun; 2014; 6(2):205-18. PubMed ID: 23969854
[TBL] [Abstract][Full Text] [Related]
4. Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system.
Rupprecht TA; Angele B; Klein M; Heesemann J; Pfister HW; Botto M; Koedel U
J Immunol; 2007 Feb; 178(3):1861-9. PubMed ID: 17237437
[TBL] [Abstract][Full Text] [Related]
5. Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis.
Oldekamp S; Pscheidl S; Kress E; Soehnlein O; Jansen S; Pufe T; Wang JM; Tauber SC; Brandenburg LO
Immunology; 2014 Nov; 143(3):447-61. PubMed ID: 24863484
[TBL] [Abstract][Full Text] [Related]
6. Lack of Proinflammatory Cytokine Interleukin-6 or Tumor Necrosis Factor Receptor-1 Results in a Failure of the Innate Immune Response after Bacterial Meningitis.
Albrecht LJ; Tauber SC; Merres J; Kress E; Stope MB; Jansen S; Pufe T; Brandenburg LO
Mediators Inflamm; 2016; 2016():7678542. PubMed ID: 27057100
[TBL] [Abstract][Full Text] [Related]
7. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
[TBL] [Abstract][Full Text] [Related]
8. Streptococcus pneumoniae Endopeptidase O (PepO) Elicits a Strong Innate Immune Response in Mice via TLR2 and TLR4 Signaling Pathways.
Zhang H; Kang L; Yao H; He Y; Wang X; Xu W; Song Z; Yin Y; Zhang X
Front Cell Infect Microbiol; 2016; 6():23. PubMed ID: 26973817
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 negatively regulates local cytokine and chemokine production but does not influence antibacterial host defense during murine pneumococcal meningitis.
Zwijnenburg PJ; van der Poll T; Florquin S; Roord JJ; van Furth AM
Infect Immun; 2003 Apr; 71(4):2276-9. PubMed ID: 12654856
[TBL] [Abstract][Full Text] [Related]
10. Mast Cells Are Activated by
Fritscher J; Amberger D; Dyckhoff S; Bewersdorf JP; Masouris I; Voelk S; Hammerschmidt S; Schmetzer HM; Klein M; Pfister HW; Koedel U
Front Immunol; 2018; 9():550. PubMed ID: 29616039
[TBL] [Abstract][Full Text] [Related]
11. Enhanced inflammation in aged mice following infection with Streptococcus pneumoniae is associated with decreased IL-10 and augmented chemokine production.
Williams AE; José RJ; Brown JS; Chambers RC
Am J Physiol Lung Cell Mol Physiol; 2015 Mar; 308(6):L539-49. PubMed ID: 25595646
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis.
Koedel U; Angele B; Rupprecht T; Wagner H; Roggenkamp A; Pfister HW; Kirschning CJ
J Immunol; 2003 Jan; 170(1):438-44. PubMed ID: 12496429
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-18 gene-deficient mice show enhanced defense and reduced inflammation during pneumococcal meningitis.
Zwijnenburg PJ; van der Poll T; Florquin S; Akira S; Takeda K; Roord JJ; van Furth AM
J Neuroimmunol; 2003 May; 138(1-2):31-7. PubMed ID: 12742650
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal application of the antimicrobial peptide CRAMP reduced mortality and neuroinflammation in an experimental model of pneumococcal meningitis.
Dörr A; Kress E; Podschun R; Pufe T; Tauber SC; Brandenburg LO
J Infect; 2015 Aug; 71(2):188-99. PubMed ID: 25896094
[TBL] [Abstract][Full Text] [Related]
15. Infection of zebrafish embryos with live fluorescent Streptococcus pneumoniae as a real-time pneumococcal meningitis model.
Jim KK; Engelen-Lee J; van der Sar AM; Bitter W; Brouwer MC; van der Ende A; Veening JW; van de Beek D; Vandenbroucke-Grauls CM
J Neuroinflammation; 2016 Aug; 13(1):188. PubMed ID: 27542968
[TBL] [Abstract][Full Text] [Related]
16. Antibody-induced neutrophil depletion prior to the onset of pneumococcal meningitis influences long-term neurological complications in mice.
Too LK; Mitchell AJ; McGregor IS; Hunt NH
Brain Behav Immun; 2016 Aug; 56():68-83. PubMed ID: 26965652
[TBL] [Abstract][Full Text] [Related]
17. MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS.
Koedel U; Rupprecht T; Angele B; Heesemann J; Wagner H; Pfister HW; Kirschning CJ
Brain; 2004 Jun; 127(Pt 6):1437-45. PubMed ID: 15115715
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil extracellular traps in the central nervous system hinder bacterial clearance during pneumococcal meningitis.
Mohanty T; Fisher J; Bakochi A; Neumann A; Cardoso JFP; Karlsson CAQ; Pavan C; Lundgaard I; Nilson B; Reinstrup P; Bonnevier J; Cederberg D; Malmström J; Bentzer P; Linder A
Nat Commun; 2019 Apr; 10(1):1667. PubMed ID: 30971685
[TBL] [Abstract][Full Text] [Related]
19. B7-H3 participates in the development of experimental pneumococcal meningitis by augmentation of the inflammatory response via a TLR2-dependent mechanism.
Chen X; Quinn EM; Ni H; Wang J; Blankson S; Redmond HP; Wang JH; Feng X
J Immunol; 2012 Jul; 189(1):347-55. PubMed ID: 22661093
[TBL] [Abstract][Full Text] [Related]
20. IL-1 receptor type 1 gene-deficient mice demonstrate an impaired host defense against pneumococcal meningitis.
Zwijnenburg PJ; van der Poll T; Florquin S; Roord JJ; Van Furth AM
J Immunol; 2003 May; 170(9):4724-30. PubMed ID: 12707352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
